Common genetic variant explains why immunotherapy often fails in Crohn's disease
The reason why a commonly used range of drugs is not effective in some patients living with Crohn’s disease has so far not been identified. However, a collaboration between the University of Exeter, Royal Devon & Exeter NHS Foundation Trust and the Wellcome Sanger Institute has discovered a genetic marker that could lead to personalized treatments for Crohn’s cases.
No comments:
Post a Comment